Pharma industry joins forces with funding council to provide 12 new PhD studentships in UK university chemistry departments
Twelve new 'EPSRC-Pharma Synthesis' PhD studentships, based in eight university UK chemistry departments, were announced in March. These studentships are part of an industry-research council collaboration launched two years ago to fund areas of research that are vital to the UK economy.
The Synthesis Programme is co-funded by the Engineering and Physical Sciences Research Council (EPSRC) and the pharmaceutical giants Pfizer, GlaxoSmithKline and AstraZeneca, and is a reflection of EPSRC's growing interest in a funding model that emphasises industrial-academic collaboration. The main objective of the programme is to maintain and strengthen support for synthetic organic chemistry research, which underpins R&D in the pharmaceutical industry.
Thanks for using Education in Chemistry. You can view one Education in Chemistry article per month as a visitor.
Registration is open to all teachers and technicians at secondary schools, colleges and teacher training institutions in the UK and Ireland.
Get all this, plus much more:
Already a Teach Chemistry member? Sign in now.
Not eligible for Teach Chemistry? Sign up for a personal account instead, or you can also access all our resources with Royal Society of Chemistry membership.